Sweden· SE-20170203000030
Steglatro 15 mg Filmdragerad tablett
A medicinal product containing ertugliflozin, registered in Sweden by Merck Sharp & Dohme BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ertugliflozin
- Manufacturer
- Merck Sharp & Dohme BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20170203000030
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ertugliflozin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSTEGLATROMerck Sharp & Dohme B.V., Haarlem
- SpainSTEGLATRO 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- IcelandSteglatroMerck Sharp & Dohme B.V.*
- PolandSteglatroMerck Sharp & Dohme B.V.
- United StatesSTEGLATROMerck Sharp & Dohme LLC
- United KingdomSteglatro 15mg tabletsMerck Sharp & Dohme (UK) Ltd
- ItalySTEGLATRO*28 cpr rivestite 15 mgMERCK SHARP & DOHME BV
- SwitzerlandSteglatro 5 mg, FilmtablettenMSD Merck Sharp & Dohme AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Steglatro
- Liechtenstein · Steglatro
- Norway · Steglatro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b77088fd-529c-493a-a47d-b81cce94b6ba GET /v1/drugs/b77088fd-529c-493a-a47d-b81cce94b6ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20170203000030",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20170203000030",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/steglatro"
}See everything about ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.